Klinikum Rechts Der Isar - Technische Universitaet Muenchen
About Klinikum Rechts Der Isar - Technische Universitaet Muenchen
The Rechts der Isar Hospital is a hospital in the Haidhausen district of Munich, Germany. It is the teaching hospital and biomedical research facility of the TUM School of Medicine.
There are 1,161 beds in Klinikum Rechts Der Isar - Technische Universitaet Muenchen.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Technical University of Munich
30
Celgene
15
European Organisation for Research and Treatment of Cancer - EORTC
11
Deutsches Herzzentrum Muenchen
9
German CLL Study Group
8
Shire
8
Hoffmann-La Roche
7
University of Ulm
7
AGO Study Group
6
Boehringer Ingelheim
6
Daiichi Sankyo, Inc.
6
Clinical Trials at Klinikum Rechts Der Isar - Technische Universitaet Muenchen
During the past decade, Klinikum Rechts Der Isar - Technische Universitaet Muenchen conducted 164 clinical trials. In the 10-year time frame, 164 clinical trials started and 62 clinical trials were completed, i.e. on
average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 38 clinical trials were completed. i.e. 84.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
1997-05-01
Unknown status
300
Combination Chemotherapy in Treating Men With Germ Cell Cancer
1998-10-01
Unknown status
498
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer
1999-04-01
Completed
222
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
1999-07-01
Terminated
144
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
2000-03-01
Unknown status
Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer
2000-04-04
2009-02-10
Completed
774
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
1999-12-01
2006-08-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" #1 sponsor was "Technical University of Munich" with 30 trials, followed by "Celgene" with 15 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials sponsored, "Deutsches Herzzentrum Muenchen" with 9 trials sponsored and "German CLL Study Group"
with 9 trials sponsored. Other sponsors include 235 different institutions and
companies that sponsored additional 151 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen"
#1 collaborator was "Technical University of Munich" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "ClinAssess GmbH" with 3 trials as a collaborator. Other collaborators include 175 different institutions and companies that were
collaborators in the rest 153 trials.
Clinical Trials Conditions at Klinikum Rechts Der Isar - Technische Universitaet Muenchen
According to Clinical.Site data, the most researched conditions in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" are
"Ovarian Cancer" (11 trials), "Acute Myeloid Leukemia" (9 trials), "Myelodysplastic Syndromes" (9 trials), "Breast Cancer" (8 trials) and "Alzheimer's Disease" (7 trials). Many other conditions were trialed in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Rechts Der Isar - Technische Universitaet Muenchen
Most popular intervention types in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" are "Drug" (215 trials), "Biological" (43 trials), "Other" (34 trials), "Device" (32 trials) and "Procedure" (27 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (55 trials), "cyclophosphamide" (9 trials), "Lenalidomide" (8 trials), "Obinutuzumab" (8 trials) and "Pembrolizumab" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Rechts Der Isar - Technische Universitaet Muenchen
The vast majority of trials in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen" are
272 trials for "All" genders, 28 trials for "Female" genders and 13 trials for "Male" genders.
Clinical Trials Status at Klinikum Rechts Der Isar - Technische Universitaet Muenchen
Currently, there are NaN active trials in "Klinikum Rechts Der Isar - Technische Universitaet Muenchen".
2 are not yet recruiting,
45 are recruiting,
47 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 146 completed trials in Klinikum Rechts Der Isar - Technische Universitaet Muenchen,
2 suspended trials,
and 35 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Rechts Der Isar - Technische Universitaet Muenchen, 23 "Phase 1"
clinical trials were conducted, 88 "Phase 2" clinical
trials and 134 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 15 trials, and there were
also 24 trials that are defined as “Not Applicable".